We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+7.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$2.13B
Cap. Flow
+$1.52B
Cap. Flow %
10.28%
Top 10 Hldgs %
17.14%
Holding
1,089
New
119
Increased
321
Reduced
473
Closed
155

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$97.2M
2
BKNG icon
Booking.com
BKNG
+$94.2M
3
PSX icon
Phillips 66
PSX
+$82.9M
4
GILD icon
Gilead Sciences
GILD
+$73.9M
5
SNOW icon
Snowflake
SNOW
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 26.09%
2 Financials 15.5%
3 Healthcare 14.12%
4 Consumer Discretionary 11.36%
5 Industrials 9.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WSR
1051
DELISTED
Whitestone REIT
WSR
-140,407
Closed -$1.19M
YEXT icon
1052
Yext
YEXT
$570M
-142,359
Closed -$635K
GAP
1053
The Gap Inc
GAP
$7.31B
-194,504
Closed -$1.6M
FFAI
1054
Faraday Future Intelligent Electric
FFAI
$10.4M
-1
Closed -$730K
VOXX
1055
DELISTED
VOXX International Corporation Class A
VOXX
-93,006
Closed -$708K
PTVE
1056
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
-15,640
Closed -$137K
HCP
1057
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
-39,984
Closed -$1.29M
INST
1058
DELISTED
Instructure Holdings, Inc.
INST
-115,960
Closed -$2.58M
BHIL
1059
DELISTED
Benson Hill, Inc.
BHIL
-3,426
Closed -$329K
ALPN
1060
DELISTED
Alpine Immune Sciences Inc
ALPN
-17,753
Closed -$128K
CURO
1061
DELISTED
CURO Group Holdings Corp.
CURO
-14,423
Closed -$58K
CRGE
1062
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
-77,590
Closed -$137K
RAIN
1063
DELISTED
Rain Oncology Inc. Common Stock
RAIN
-22,635
Closed -$110K
VAPO
1064
DELISTED
Vapotherm, Inc. Common Stock
VAPO
-9,854
Closed -$124K
FORG
1065
DELISTED
ForgeRock, Inc.
FORG
-28,572
Closed -$415K
SPPI
1066
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-594,108
Closed -$255K
AJRD
1067
DELISTED
Aerojet Rocketdyne Holdings
AJRD
-932,878
Closed -$37.3M
BGRY
1068
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
-261,704
Closed -$445K
RXDX
1069
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
-133,831
Closed -$7.9M
TCRR
1070
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-83,360
Closed -$150K
SI
1071
DELISTED
Silvergate Capital Corporation
SI
-51,401
Closed -$3.87M
BBBY
1072
DELISTED
Bed Bath & Beyond Inc
BBBY
-129,539
Closed -$789K
IAA
1073
DELISTED
IAA, Inc. Common Stock
IAA
-321,717
Closed -$10.2M
LYLT
1074
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
-42,793
Closed -$52K
RUBY
1075
DELISTED
Rubius Therapeutics, Inc
RUBY
-544,238
Closed -$236K

Similar funds

Jacobs Levy Equity Management's Q4 2022 Portfolio in Review

As of Q4 2022, Jacobs Levy Equity Management held 1,089 positions worth $14.8B, up 17% from $12.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Jacobs Levy Equity Management deployed $1.52B of net new capital in Q4 2022, opening 119 new positions and adding to 321 existing holdings. Its largest new stake was Fidelity National Information Services: 1,326,663 shares worth $90M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Booking.com, an estimated $94.2M trimmed.

  • Jacobs Levy Equity Management's largest Q4 2022 buy was Fidelity National Information Services: 1,326,663 shares worth $90M.
  • Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q4 2022, an estimated $132M increase.
  • Jacobs Levy Equity Management's biggest Q4 2022 reduction was Booking.com, cutting an estimated $94.2M.
  • Jacobs Levy Equity Management fully exited Cigna in Q4 2022, selling an estimated $97.2M.
  • Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q4 2022.
  • Jacobs Levy Equity Management opened 119 new positions and closed 155 in Q4 2022.
  • Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $14.8B.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2022, filed 14 Feb 2023.